Chronic obstructive pulmonary disease (COPD)
618 results
101 - 200Vitamin D for the management of chronic obstructive pulmonary disease
Guidelines for COPD (ACP)
Prevalence of pulmonary embolism is 5.9% in patients with COPD who are hospitalized with acute respiratory symptoms
Anti‐IL‐5 therapies for chronic obstructive pulmonary disease
Proton pump inhibitors for chronic obstructive pulmonary disease
Bisoprolol does not reduce exacerbations in adults with chronic obstructive pulmonary disease (BICS)
Summary of GOLD guideline for COPD
Guidelines for the management of COPD
Smoking cessation for chronic obstructive pulmonary disease
Tiotropium for stable chronic obstructive pulmonary disease
Hyperventilation
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review
The effect of adding inhaled corticosteroids to tiotropium and long-acting beta 2 -agonists for chronic obstructive pulmonary disease: Cochrane systematic review
Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review
Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease
Domiciliary oxygen for chronic obstructive pulmonary disease
Corticosteroids benefit patients with moderate to severe COPD
Inhaled budesonide for COPD not associated with pneumonia
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
Curable causes of cognitive challenges and memory disease
Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease
Oral = IV prednisolone for COPD exacerbation
Improved outcomes with azithromycin vs beta-lactams for acute exacerbations of chronic obstructive pulmonary disease
In high-risk patients with chronic obstructive pulmonary disease, dupilumab slightly reduces moderate exacerbation (BOREAS)
Uncertain benefit of home noninvasive positive pressure ventilation for adults with chronic obstructive pulmonary disease
Cardioselective beta‐blockers for chronic obstructive pulmonary disease
Self-management teaching not helpful for COPD
Inhaled steroids only decrease COPD exacerbations slightly
Breathing exercises for chronic obstructive pulmonary disease: Cochrane systematic review
Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease
Breathing exercises for chronic obstructive pulmonary disease
Antibiotic and corticosteroid treatment effective for acute exacerbations of COPD
Anticholinergics of greater benefit in COPD treatment
Physician assessment of COPD doesn't match spirometry results
Active mind‐body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease
Telehealthcare for chronic obstructive pulmonary disease
USPSTF: D recommendation against screening for COPD in asymptomatic adults
Inhaled corticosteroids increase pneumonia risk in stable COPD
Corticosteroids, selective use of antibiotics and NPPV for COPD exacerbations
Tiotropium mist associated with mortality in COPD treatment
Azithromycin of questionable benefit given daily for COPD
Fluticasone plus vilanterol an option for COPD
Long-term erythromycin decreases COPD exacerbations
Simple risk score predicts severity of COPD exacerbations
American Thoracic Society home oxygen guideline for patients with COPD or interstitial lung disease
3-in-1 inhaler for chronic obstructive pulmonary disease may provide better outcomes than multiple individual inhalers (SKOPOS-MAZI)
Smoking cessation for people with chronic obstructive pulmonary disease
Supplemental oxygen ineffective for COPD with moderate hypoxemia
Inhaled steroids for COPD associated with increased risk of pneumonia
Tiotropium not associated with increase cardiovascular risk in patients with COPD
Long-acting bronchodilators similarly safe in COPD patients
Inhaled short‐acting beta2‐agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease
Home care by outreach nursing for chronic obstructive pulmonary disease
Pneumococcal vaccines for patients with chronic obstructive pulmonary disease
Procalcitonin test can reduce antibiotic use in COPD
Dyspnoea
Singing for adults with chronic obstructive pulmonary disease
For mild to severe COPD exacerbations, antibiotics and steroids remain the mainstay of treatment
Sputum purulence and CRP predict poor prognosis with COPD exacerbation
5-day steroid treatment effective for acute COPD exacerbation
Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease: Cochrane systematic review
Tiotropium versus placebo for chronic obstructive pulmonary disease
Inhaled anticholinergics associated with increased risk of CVD in COPD
Fluticasone + salmeterol may reduce mortality but also increase pneumonia in COPD
Salmeterol + fluticasone better than tiotropium in COPD (INSPIRE)
COPD -- combo therapy improves symptoms but doesn't decrease exacerbations
Better outcomes with noninvasive ventilation for hospitalized COPD patients
Reduced readmissions with home NIV plus oxygen for COPD exacerbation with persistent hypercapnia
Acute bronchitis
Helium-oxygen improves exercise tolerance in pts with COPD
Chronic non‐invasive ventilation for chronic obstructive pulmonary disease
No change in duration of mechanical ventilation with acetazolamide for COPD patients with metabolic alkalosis
Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease
Pressurised metered‐dose inhalers versus all other hand‐held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease
High-efficiency air cleaners decrease exacerbations and the use of rescue medication in former smokers with COPD
Short-course antibiotics effective for acute exacerbation of COPD
Self-management training, routine monitoring not effective for COPD
DECAF score provides accurate prognosis for patients with acute exacerbation of COPD
Low-dose theophylline is minimally helpful, if at all, in preventing COPD exacerbations
Amox-clavulanate during COPD exacerbations decreases Sx and delays subsequent exacerbations
Beta-blockers associated with improved morbidity/mortality in COPD patients
Mepolizumab provides a small reduction in the exacerbations of moderate to severe eosinophilic COPD
Tiotropium via Soft Mist Inhaler increases all-cause mortality in COPD